UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...

Another man described a similar experience on Mumsnet. ‘If I masturbate or have sex there is literally no pleasure. It’s a ...

It’s estimated that around 7 million Americans have Alzheimer’s disease, a number that’s expected to double by 2060. But researchers have found that some of the highest rates of cognitive impairment ...

"Spinogenix’s Alzheimer’s drug touts disease-modifying potential in Phase IIa study" was originally created and published by ...

Monash University will today launch Victoria’s most advanced, research-dedicated MRI scanner to support world-class researchers as they accelerate breakthroughs in critical health challenges like ...

Bristol Myers jumps after choosing to continue its phase III ADEPT-2 study on Cobenfy for Alzheimer-related psychosis, delaying data to next year.

Monash University will today launch Victoria's most advanced, research-dedicated MRI scanner to support world-class researchers as they accelerate ...

Bristol Myers will enroll more patients in its Cobenfy Alzheimer's psychosis study after site irregularities, with FDA-supported analysis suggesting encouraging early signals.

Study Continuation Follows Review of Site Level Data and Recommendation of Data Monitoring CommitteeBMS Remains Blinded to Study DataPRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY, ...

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...

New brain imaging research shows that structural damage in schizophrenia spectrum disorders may begin in specific “epicenter” regions before spreading across connected brain networks.

Presenter: Audrey Gabelle, MD, PhD, Professor of Neurology, Neurologist and Member of the Anavex Scientific Advisory Board and Doctor in Neurosciences at the Memory Resources Research Center, the Rare ...